[HTML][HTML] Recent advances in nanomaterials for gene delivery—a review

MK Riley, W Vermerris - Nanomaterials, 2017 - mdpi.com
With the rapid development of nanotechnology in the recent decade, novel DNA and RNA
delivery systems for gene therapy have become available that can be used instead of viral …

Polysaccharide-based nanoparticles for theranostic nanomedicine

M Swierczewska, HS Han, K Kim, JH Park… - Advanced drug delivery …, 2016 - Elsevier
Polysaccharides are natural biological molecules that have numerous advantages for
theranostics, the integrated approach of therapeutics and diagnostics. Their derivable …

Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment

ZJ Deng, SW Morton, E Ben-Akiva, EC Dreaden… - ACS …, 2013 - ACS Publications
A single nanoparticle platform has been developed through the modular and controlled
layer-by-layer process to codeliver siRNA that knocks down a drug-resistance pathway in …

Nanoparticle characterization: state of the art, challenges, and emerging technologies

EJ Cho, H Holback, KC Liu… - Molecular …, 2013 - ACS Publications
Nanoparticles have received enormous attention as a promising tool to enhance target-
specific drug delivery and diagnosis. Various in vitro and in vivo techniques are used to …

Inorganic nanoparticles for cancer imaging and therapy

HC Huang, S Barua, G Sharma, SK Dey… - Journal of controlled …, 2011 - Elsevier
Inorganic nanoparticles have received increased attention in the recent past as potential
diagnostic and therapeutic systems in the field of oncology. Inorganic nanoparticles have …

Nanoengineered polymeric rna nanoparticles for controlled biodistribution and efficient targeted cancer therapy

T Kim, HS Han, K Yang, YM Kim, K Nam, KH Park… - ACS …, 2024 - ACS Publications
RNA nanotechnology, including rolling circle transcription (RCT), has gained increasing
interest as a fascinating siRNA delivery nanoplatform for biostable and tumor-targetable …

Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo

Y Zhong, K Goltsche, L Cheng, F **e, F Meng, C Deng… - Biomaterials, 2016 - Elsevier
The therapeutic efficacy of nanoscale anticancer drug delivery systems is severely truncated
by their low tumor-targetability and inefficient drug release at the target site. Here, we report …

Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives

EJ Oh, K Park, KS Kim, J Kim, JA Yang, JH Kong… - Journal of Controlled …, 2010 - Elsevier
Hyaluronic acid (HA) is a biodegradable, biocompatible, non-toxic, non-immunogenic and
non-inflammatory linear polysaccharide, which has been used for various medical …

Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts

Y Zhong, J Zhang, R Cheng, C Deng, F Meng… - Journal of controlled …, 2015 - Elsevier
The existence of drug resistance poses a major obstacle for the treatment of various
malignant human cancers. Here, we report on reduction-sensitive reversibly crosslinked …

Nanomaterials for cancer precision medicine

Y Wang, S Sun, Z Zhang, D Shi - Advanced materials, 2018 - Wiley Online Library
Medical science has recently advanced to the point where diagnosis and therapeutics can
be carried out with high precision, even at the molecular level. A new field of “precision …